Ajit K. Verma - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
Oncology, Cell Biology, Biochemistry
Website:
https://www.humonc.wisc.edu/team_member/ajit-verma-phd/

104 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Bin Hafeez B, Meske L, Singh A, Singh A, Zhong W, Powers P, John M, Griep AE, Verma AK. Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer. Oncotarget. PMID 27102301 DOI: 10.18632/Oncotarget.8850  0.6
2016 Singh A, Willems E, Singh A, Hafeez BB, Ong IM, Mehta SL, Verma AK. Ultraviolet radiation-induced tumor necrosis factor alpha, which is linked to the development of cutaneous SCC, modulates differential epidermal microRNAs expression. Oncotarget. PMID 26918454 DOI: 10.18632/Oncotarget.7595  0.6
2015 Singh A, Singh A, Bauer SJ, Wheeler DL, Havighurst TC, Kim K, Verma AK. Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals. Carcinogenesis. PMID 26586792 DOI: 10.1093/Carcin/Bgv162  0.6
2015 Hafeez BB, Fischer JW, Singh A, Zhong W, Mustafa A, Meske L, Sheikhani MO, Verma AK. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers. Cancer Prevention Research (Philadelphia, Pa.). 8: 375-86. PMID 25627799 DOI: 10.1158/1940-6207.Capr-14-0231  0.36
2015 Singh A, Singh A, Sand JM, Bauer SJ, Hafeez BB, Meske L, Verma AK. Topically applied Hsp90 inhibitor 17AAG inhibits UVR-induced cutaneous squamous cell carcinomas. The Journal of Investigative Dermatology. 135: 1098-107. PMID 25337691 DOI: 10.1038/Jid.2014.460  0.68
2015 Hafeez BB, Meske L, Singh A, Singh A, Zhong W, Powers P, John M, Griep A, Verma A. Abstract LB-137: Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-137  0.32
2015 Thaduri A, Verma AK, Kumar U. Comparison of failure characteristics of different electronic technologies by using modified physics-of-failure approach International Journal of Systems Assurance Engineering and Management. 6: 198-205. DOI: 10.1007/S13198-014-0301-Y  0.01
2015 Arul AJ, Iyer K, Verma AK. Generalized hybrid approach to adjoint code derivation for efficient uncertainty and reliability studies International Journal of Systems Assurance Engineering and Management. 6: 172-182. DOI: 10.1007/S13198-014-0265-Y  0.01
2015 Verma AK, Srividya A, Rana A. Use of stochastic petrinets in modeling of safety device inspection interval problem International Journal of Systems Assurance Engineering and Management. 6: 165-171. DOI: 10.1007/S13198-014-0264-Z  0.01
2014 Hafeez BB, Mustafa A, Fischer JW, Singh A, Zhong W, Shekhani MO, Meske L, Havighurst T, Kim K, Verma AK. α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model. Antioxidants & Redox Signaling. 21: 682-99. PMID 24295217 DOI: 10.1089/Ars.2013.5212  0.32
2014 Hafeez BB, Fischer JW, Singh A, Mustafa A, Meske L, Verma AK. Abstract 2142: Plumbagin, a medicinal plant-derived 1,4-napthoquinone, inhibits prostate carcinogenesis in intact and castratedPtenknockout mice by modulation of tumor microenvironment Cancer Research. 74: 2142-2142. DOI: 10.1158/1538-7445.Am2014-2142  0.32
2014 Khan MI, Adhami VM, Haidar OM, Hafeez BB, Verma AK, Mukhtar H. Abstract 1437: PTEN deficiency in prostate epithelial cells is associated with increased CAD phosphorylation and is inhibited by fisetin Cancer Research. 74: 1437-1437. DOI: 10.1158/1538-7445.Am2014-1437  0.32
2013 Wheeler DL, Verma AK, Denning MF. Mouse models of the skin: models to define mechanisms of skin carcinogenesis. Journal of Skin Cancer. 2013: 971495. PMID 23819053 DOI: 10.1155/2013/971495  0.68
2013 Singh A, Singh A, Sand JM, Heninger E, Hafeez BB, Verma AK. Protein Kinase C ε , Which Is Linked to Ultraviolet Radiation-Induced Development of Squamous Cell Carcinomas, Stimulates Rapid Turnover of Adult Hair Follicle Stem Cells. Journal of Skin Cancer. 2013: 452425. PMID 23738074 DOI: 10.1155/2013/452425  0.68
2013 Hafeez BB, Zhong W, Fischer JW, Mustafa A, Shi X, Meske L, Hong H, Cai W, Havighurst T, Kim K, Verma AK. Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model. Molecular Oncology. 7: 428-39. PMID 23273564 DOI: 10.1016/J.Molonc.2012.12.001  0.32
2013 Singh A, Bauer SJ, Singh A, Sand JM, Hafeez BB, Meske L, Verma AK. Abstract 4875: Topically applied Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas. Cancer Research. 73: 4875-4875. DOI: 10.1158/1538-7445.Am2013-4875  0.68
2013 Khan MI, Adhami VM, Lall RK, Syed DN, Siddiqui IA, Hafeez BB, Verma AK, Mukhtar H. Abstract 4312: Grb10, a negative regulator of insulin signaling, is a tumor suppressor in prostate cancer. Cancer Research. 73: 4312-4312. DOI: 10.1158/1538-7445.Am2013-4312  0.32
2012 Hafeez BB, Zhong W, Mustafa A, Fischer JW, Witkowsky O, Verma AK. Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers. Carcinogenesis. 33: 2586-92. PMID 22976928 DOI: 10.1093/Carcin/Bgs291  0.36
2012 Hafeez BB, Jamal MS, Fischer JW, Mustafa A, Verma AK. Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways. International Journal of Cancer. Journal International Du Cancer. 131: 2175-86. PMID 22322442 DOI: 10.1002/Ijc.27478  0.36
2012 Sand JM, Bin Hafeez B, Jamal MS, Witkowsky O, Siebers EM, Fischer J, Verma AK. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomas. Carcinogenesis. 33: 184-90. PMID 22072620 DOI: 10.1093/Carcin/Bgr249  0.68
2012 Sand JM, Bin Hafeez B, Aziz MH, Siebers EM, Dreckschmidt NE, Verma AK. Ultraviolet radiation and 12-O-tetradecanoylphorbol-13-acetate-induced interaction of mouse epidermal protein kinase Cε with Stat3 involve integration with ERK1/2. Molecular Carcinogenesis. 51: 291-302. PMID 21480396 DOI: 10.1002/Mc.20776  0.68
2012 Jamal MS, Hafeez BB, Verma AK. Abstract LB-65: Protein kinase Cε, which is linked to development of squamous cell carcinomas, potentiates ultraviolet radiation-induced expression of novel transcription factors GATA and PAX, which regulates expression of cell survival genes Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-65  0.36
2012 Hafeez BB, Zhong W, Fischer JW, Mustafa A, Verma A. Abstract 5637: Plumbagin, a plant derived napthoquinone, inhibits the metastatic growth of human prostate cancer PC-3M luciferase cells in an orthotropic xenograft mouse model Cancer Research. 72: 5637-5637. DOI: 10.1158/1538-7445.Am2012-5637  0.32
2012 Hafeez BB, Fischer JW, Mustafa A, Zhong W, Verma AK. Abstract 5418: α-Mangostin, a dietary xanthone, inhibits ectopic xenograft growth of pancreatic cancer cells in an athymic nude mice Cancer Research. 72: 5418-5418. DOI: 10.1158/1538-7445.Am2012-5418  0.32
2012 Haque A, Jamal MS, Meske L, Hafeez BB, Verma AK. Abstract 2547: Protein kinase C epsilon and protein kinase C delta, which are linked to skin carcinogenesis, associate with heat shock protein 90 beta Cancer Research. 72: 2547-2547. DOI: 10.1158/1538-7445.Am2012-2547  0.36
2011 Hafeez BB, Zhong W, Weichert J, Dreckschmidt NE, Jamal MS, Verma AK. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma. Cancer Research. 71: 2318-27. PMID 21406403 DOI: 10.1158/0008-5472.Can-10-4170  0.68
2011 Hafeez B, Zhong W, Weichart J, Jamal M, Haque A, Verma A. Abstract PR-06: PKC∈-activated Stat3 and subsequent AR interaction are potential molecular targets for prevention of late-stage prostate cancer Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-Pr-06  0.32
2011 Jamal MS, Verma AK. Abstract LB-343: Ultraviolet radiation modulates distinct mouse epidermal miRNAs expression profile Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-343  0.36
2011 Jamal MS, Hafeez BB, Verma AK. Abstract 4204: Chronic ultraviolet radiation exposure of mouse skin activates GATA and PAX families of transcription factors, which regulate expression of cell survival genes Cancer Research. 71: 4204-4204. DOI: 10.1158/1538-7445.Am2011-4204  0.36
2011 Hafeez BB, Zhong W, Weichert J, Jamal MS, Verma AK. Abstract 1614: Genetic loss of PKC epsilon inhibits development and metastasis of prostate cancer in transgenic adenocarcinoma of mouse prostate model Cancer Research. 71: 1614-1614. DOI: 10.1158/1538-7445.Am2011-1614  0.36
2011 Hafeez BB, Zhong W, Verma AK. Abstract 1165: PKC epsilon modulated miRNAs profiling during development of prostate cancer in transgenic adenocarcinoma of mouse prostate model Cancer Research. 71: 1165-1165. DOI: 10.1158/1538-7445.Am2011-1165  0.32
2010 Aziz MH, Hafeez BB, Sand JM, Pierce DB, Aziz SW, Dreckschmidt NE, Verma AK. Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). Oncogene. 29: 3100-9. PMID 20228845 DOI: 10.1038/Onc.2010.63  0.68
2010 Bailey HH, Kim K, Verma AK, Sielaff K, Larson PO, Snow S, Lenaghan T, Viner JL, Douglas J, Dreckschmidt NE, Hamielec M, Pomplun M, Sharata HH, Puchalsky D, Berg ER, et al. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prevention Research (Philadelphia, Pa.). 3: 35-47. PMID 20051371 DOI: 10.1158/1940-6207.Capr-09-0096  0.6
2010 Sand JM, Aziz MH, Dreckschmidt NE, Havighurst TC, Kim K, Oberley TD, Verma AK. PKCepsilon overexpression, irrespective of genetic background, sensitizes skin to UVR-induced development of squamous-cell carcinomas. The Journal of Investigative Dermatology. 130: 270-7. PMID 19626035 DOI: 10.1038/Jid.2009.212  0.68
2010 Hafeez BB, Dreckschmidt NE, Verma AK. Abstract LB-424: Plumbagin, a medicinal plant-derived napthoquinone, inhibits the growth of pancreatic cancer cells inin vitroandin vivoxenograft mouse model systems via targeting NFkB and STAT3 signaling network Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-424  0.68
2010 Sand JM, Dreckschmidt NE, Wheeler DL, Oberley TD, Verma AK. Abstract 5151: Protein kinase Cε, which is linked to development of squamous cell carcinomas, potentiates ultraviolet radiation-induced proliferation of hair follicle putative stem cells Cancer Research. 70: 5151-5151. DOI: 10.1158/1538-7445.Am10-5151  0.68
2010 Hafeez BB, Dreckschmidt NE, Colson LA, Verma AK. Abstract 3800: Dietary agent α-Mangostin inhibits growth of pancreatic cancer BxPC3 and PANC1 cells and arrests the cell cycle in G0/G1 phase: Involvement of Ras, Hedgehog, NF-kB, and STAT3 signaling networks Cancer Research. 70: 3800-3800. DOI: 10.1158/1538-7445.Am10-3800  0.68
2010 Hafeez BB, Colson LA, Verma AK. Abstract 3780: Plumbagin a non-toxic natural agent, induces apoptosis and inhibits the growth of prostate cancer LNCaP and C4-2 cells via blocking of both androgen and non-androgen activation of androgen receptor signaling Cancer Research. 70: 3780-3780. DOI: 10.1158/1538-7445.Am10-3780  0.32
2010 Sand JM, Siebers EM, Dreckschmidt NE, Verma AK. Abstract 1881: Plumbagin, a medicinal plant-derived naphthoquinone, inhibits ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas Cancer Research. 70: 1881-1881. DOI: 10.1158/1538-7445.Am10-1881  0.68
2010 Sand JM, Siebers EM, Verma AK. Abstract 1591: Protein kinase Cε, which is linked to ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Hsp90β, a core component of multiprotein complex inolving several collaborating chaperones Hsp70/Hsp40, Hop/sti, Cdc37 and p21 Cancer Research. 70: 1591-1591. DOI: 10.1158/1538-7445.Am10-1591  0.68
2010 Verma AK, Aziz MH, Aggarwal BB. Abstract 1583: Plumbagin, a medicinal plant-derived naphthoquinone with both chemopreventive and therapeutic properties, selectively inhibits expression of Protein Kinase Cε, a predictive biomarker of prostate cancer progression Cancer Research. 70: 1583-1583. DOI: 10.1158/1538-7445.Am10-1583  0.44
2009 Aziz MH, Sundling KE, Dreckschmidt NE, Verma AK. Protein kinase Cepsilon inhibits UVR-induced expression of FADD, an adaptor protein, linked to both Fas- and TNFR1-mediated apoptosis. The Journal of Investigative Dermatology. 129: 2011-21. PMID 19194472 DOI: 10.1038/Jid.2008.458  0.6
2008 Aziz MH, Dreckschmidt NE, Verma AK. Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Research. 68: 9024-32. PMID 18974148 DOI: 10.1158/0008-5472.Can-08-2494  0.68
2007 Li Y, Wheeler DL, Ananthaswamy HN, Verma AK, Oberley TD. Differential tumor biology effects of double-initiation in a mouse skin chemical carcinogenesis model comparing wild type versus protein kinase Cepsilon overexpression mice. Toxicologic Pathology. 35: 942-51. PMID 18098040 DOI: 10.1080/01926230701748164  0.6
2007 Aziz MH, Manoharan HT, Church DR, Dreckschmidt NE, Zhong W, Oberley TD, Wilding G, Verma AK. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Research. 67: 8828-38. PMID 17875724 DOI: 10.1158/0008-5472.Can-07-1604  0.6
2007 Aziz MH, Manoharan HT, Sand JM, Verma AK. Protein kinase Cepsilon interacts with Stat3 and regulates its activation that is essential for the development of skin cancer. Molecular Carcinogenesis. 46: 646-53. PMID 17583567 DOI: 10.1002/Mc.20356  0.6
2007 Aziz MH, Manoharan HT, Verma AK. Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Cancer Research. 67: 1385-94. PMID 17283176 DOI: 10.1158/0008-5472.CAN-06-3350  0.6
2006 Verma AK, Wheeler DL, Aziz MH, Manoharan H. Protein kinase Cepsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer. Molecular Carcinogenesis. 45: 381-8. PMID 16683253 DOI: 10.1002/Mc.20230  0.6
2006 Aziz MH, Wheeler DL, Bhamb B, Verma AK. Protein kinase C delta overexpressing transgenic mice are resistant to chemically but not to UV radiation-induced development of squamous cell carcinomas: a possible link to specific cytokines and cyclooxygenase-2. Cancer Research. 66: 713-22. PMID 16424000 DOI: 10.1158/0008-5472.CAN-05-2684  0.6
2006 Verma AK. Polyamines and cancer Polyamine Cell Signaling: Polyamine Cell Signaling. 313-328. DOI: 10.1007/978-1-59745-145-1_18  0.6
2005 Li Y, Wheeler DL, Alters W, Chaiswing L, Verma AK, Oberley TD. Early epidermal destruction with subsequent epidermal hyperplasia is a unique feature of the papilloma-independent squamous cell carcinoma phenotype in PKCepsilon overexpressing transgenic mice. Toxicologic Pathology. 33: 684-94. PMID 16243773 DOI: 10.1080/01926230500323441  0.6
2005 Wheeler DL, Reddig PJ, Ness KJ, Leith CP, Oberley TD, Verma AK. Overexpression of protein kinase C-{epsilon} in the mouse epidermis leads to a spontaneous myeloproliferative-like disease. The American Journal of Pathology. 166: 117-26. PMID 15632005 DOI: 10.1016/S0002-9440(10)62237-7  0.6
2005 Wheeler DL, Li Y, Verma AK. Protein kinase C epsilon signals ultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through Induction of specific cytokines in a paracrine mechanism. Photochemistry and Photobiology. 81: 9-18. PMID 15458367 DOI: 10.1562/2004-08-12-Ra-271.1  0.6
2004 Wheeler DL, Martin KE, Ness KJ, Li Y, Dreckschmidt NE, Wartman M, Ananthaswamy HN, Mitchell DL, Verma AK. Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas. Cancer Research. 64: 7756-65. PMID 15520180 DOI: 10.1158/0008-5472.Can-04-1881  0.6
2003 Wheeler DL, Ness KJ, Oberley TD, Verma AK. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice. Cancer Research. 63: 6547-55. PMID 14559850  0.6
2003 Wheeler DL, Ness KJ, Oberley TD, Verma AK. Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss. Cancer Research. 63: 3037-42. PMID 12810623  0.6
2002 Elegbede JA, Hayes K, Schell K, Oberley TD, Verma AK. Induction of apoptosis and inhibition of papilloma formation may signal a new role for okadaic acid. Life Sciences. 71: 421-36. PMID 12044842 DOI: 10.1016/S0024-3205(02)01701-0  0.68
2002 Wheeler DL, Reddig PJ, Dreckschmidt NE, Leitges M, Verma AK. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression. Oncogene. 21: 3620-30. PMID 12032864 DOI: 10.1038/Sj.Onc.1205451  0.68
2001 Jansen AP, Dreckschmidt NE, Verwiebe EG, Wheeler DL, Oberley TD, Verma AK. Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. International Journal of Cancer. 93: 635-43. PMID 11477572 DOI: 10.1002/Ijc.1395  0.6
2001 Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL, Colburn NH. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene. 20: 669-76. PMID 11314000 DOI: 10.1038/Sj.Onc.1204137  0.6
2001 Jansen AP, Verwiebe EG, Dreckschmidt NE, Wheeler DL, Oberley TD, Verma AK. Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Research. 61: 808-12. PMID 11221859  0.6
1999 Jansen AP, Colburn NH, Verma AK. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation. Oncogene. 18: 5806-13. PMID 10523861 DOI: 10.1038/Sj.Onc.1202965  0.6
1999 Messing EM, Love RR, Tutsch KD, Verma AK, Douglas J, Pomplun M, Simsiman R, Wilding G. Low-dose difluoromethylornithine and polyamine levels in human prostate tissue Journal of the National Cancer Institute. 91: 1416-1417. PMID 10451448 DOI: 10.1093/Jnci/91.16.1416  0.6
1994 Petereit DG, Harari PM, Contreras L, Pickart MA, Verma AK, Gerner EW, Kinsella TJ. Combining polyamine depletion with radiation therapy for rapidly dividing head and neck tumors: Strategies for improved locoregional control International Journal of Radiation Oncology, Biology, Physics. 28: 891-898. PMID 8138442 DOI: 10.1016/0360-3016(94)90109-0  0.6
1994 Denning MF, Verma AK. The mechanism of the inhibition of squamous differentiation of rat tracheal 2c5 cells by retinoic acid Carcinogenesis. 15: 503-507. PMID 7509732 DOI: 10.1093/Carcin/15.3.503  0.6
1993 Love RR, Carbone PP, Verma AK, Gilmore D, Carey P, Tutsch KD, Pomplun M, Wilding G. Randomized phase I chemoprevention dose-seeking study of α-difluoromethylornithine Journal of the National Cancer Institute. 85: 732-737. PMID 8478959 DOI: 10.1093/Jnci/85.9.732  0.6
1991 Spruce LW, Gale JB, Berlin KD, Verma AK, Breitman TR, Ji XH, van der Helm D. Novel heteroarotinoids: synthesis and biological activity. Journal of Medicinal Chemistry. 34: 430-9. PMID 1992144  0.6
1991 Denning MF, Verma AK. Involvement of retinoic acid nuclear receptors in retinoic acid-induced tissue transglutaminase gene expression in rat tracheal 2C5 cells Biochemical and Biophysical Research Communications. 175: 344-350. PMID 1705423 DOI: 10.1016/S0006-291X(05)81241-0  0.6
1990 Verma AK. Inhibition of tumor promotion by DL-alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase Basic Life Sciences. 52: 195-204. PMID 2109593 DOI: 10.1007/978-1-4615-9561-8_16  0.6
1989 Verma AK. The enzyme-activated irreversible inhibitor of ornithine decarboxylase, dl-α-difluoromethylornithine: A chemopreventive agent Preventive Medicine. 18: 646-652. PMID 2515533 DOI: 10.1016/0091-7435(89)90035-2  0.6
1987 Spruce LW, Rajadhyaksha SN, Berlin KD, Gale JB, Miranda ET, Ford WT, Blossey EC, Verma AK, Hossain MB, van der Helm D. Heteroarotinoids. Synthesis, characterization, and biological activity in terms of an assessment of these systems to inhibit the induction of ornithine decarboxylase activity and to induce terminal differentiation of HL-60 cells. Journal of Medicinal Chemistry. 30: 1474-82. PMID 3612691 DOI: 10.1021/Jm00391A033  0.6
1985 Verma AK, Loprinzi CL, Boutwell RK, Carbone PP. In vitro induction of human skin ornithine decarboxylase by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Journal of the National Cancer Institute. 75: 85-90. PMID 3859699 DOI: 10.1093/Jnci/75.1.85  1
1985 Loprinzi CL, Verma AK, Boutwell RK, Carbone PP. Inhibition of phorbol ester--induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 3: 751-7. PMID 3859584 DOI: 10.1200/Jco.1985.3.6.751  1
1985 Verma AK. Inhibition of phorbol ester-caused synthesis of mouse epidermal ornithine decarboxylase by retinoic acid Bba - Molecular Cell Research. 846: 109-119. PMID 2861859 DOI: 10.1016/0167-4889(85)90116-8  0.6
1983 Takigawa M, Verma AK, Simsiman RC, Boutwell RK. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine. Cancer Research. 43: 3732-8. PMID 6407752  1
1983 Verma AK, Garcia CT, Ashendel CL, Boutwell RK. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Cancer Research. 43: 3045-9. PMID 6406052  1
1983 Boutwell RK, Takigawa M, Verma AK, Ashendel CL. Observations on the mechanism of skin tumor promotion by phorbol esters. Princess Takamatsu Symposia. 14: 177-93. PMID 6240487  1
1982 Takigawa M, Verma AK, Simsiman RC, Boutwell RK. Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine. Biochemical and Biophysical Research Communications. 105: 969-76. PMID 6807316 DOI: 10.1016/0006-291X(82)91065-8  1
1982 Boutwell RK, Verma AK, Ashendel CL, Astrup E. Mouse skin: a useful model system for studying the mechanism of chemical carcinogenesis. Carcinogenesis; a Comprehensive Survey. 7: 1-12. PMID 6802487  1
1982 Verma AK, Conrad EA, Boutwell RK. Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Cancer Research. 42: 3519-25. PMID 6286109  1
1981 Verma AK, Boutwell RK. Characterization of arginase activity from mouse epidermis and its relation to ornithine decarboxylase induction by the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate. Biochimica Et Biophysica Acta. 677: 184-9. PMID 7295793 DOI: 10.1016/0304-4165(81)90083-0  1
1981 Verma AK, Boutwell RK. Intracellular calcium and skin tumor promotion: calcium regulation of the induction of epidermal ornithine decarboxylase activity by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Biochemical and Biophysical Research Communications. 101: 375-83. PMID 6796074 DOI: 10.1016/0006-291X(81)91270-5  1
1981 Boutwell RK, Verma AK. The influence of retinoids on polyamine and DNA synthesis in mouse epidermis. Annals of the New York Academy of Sciences. 359: 275-80. PMID 6789744  1
1980 Verma AK, Boutwell RK. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis. Carcinogenesis. 1: 271-6. PMID 22283009 DOI: 10.1093/Carcin/1.3.271  1
1980 Verma AK, Conrad EA, Boutwell RK. Induction of mouse epidermal ornithine decarboxylase activity and skin tumors by 7,12-dimethylben. Carcinogenesis. 1: 607-11. PMID 11219836 DOI: 10.1093/Carcin/1.7.607  1
1980 Weekes RG, Verma AK, Boutwell RK. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Research. 40: 4013-8. PMID 7471050  1
1980 Verma AK, Boutwell RK. An organ culture of adult mouse skin: an in vitro model for studying the molecular mechanism of skin tumor promotion. Biochemical and Biophysical Research Communications. 96: 854-62. PMID 7426016 DOI: 10.1016/0006-291X(80)91434-5  1
1980 Verma AK, Slaga TJ, Wertz PW, Mueller GC, Boutwell RK. Inhibition of skin tumor promotion by retinoic acid and its metabolite 5,6-epoxyretinoic acid. Cancer Research. 40: 2367-71. PMID 7388798  1
1980 Verma AK, Ashendel CL, Boutwell RK. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Research. 40: 308-15. PMID 6243250  1
1979 Verma AK, Shapas BG, Rice HM, Boutwell RK. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Research. 39: 419-25. PMID 761215  1
1979 Wertz PW, Kensler TW, Mueller GC, Verma AK, Boutwell RK. 5,6-epoxyretinoic acid opposes the effects of 12-O-tetradecanoylphorbol-13-acetate in bovine lymphocytes. Nature. 277: 227-9. PMID 551250 DOI: 10.1038/277227A0  1
1979 Verma AK, Lowe NJ, Boutwell RK. Induction of mouse epidermal ornithine decarboxylase activity and DNA synthesis by ultraviolet light. Cancer Research. 39: 1035-40. PMID 427744  1
1979 Mufson RA, Fischer SM, Verma AK, Gleason GL, Slaga TJ, Boutwell RK. Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3':5'-monophosphate, and induction of mouse skin tumors in vivo. Cancer Research. 39: 4791-5. PMID 227591  1
1978 Boutwell RK, O'Brien TG, Verma AK, Weekes RG, DeYoung LM, Ashendel CL, Astrup EG. The induction of ornithine decarboxylase activity and its control in mouse skin epidermis. Advances in Enzyme Regulation. 17: 89-112. PMID 757315 DOI: 10.1016/0065-2571(79)90009-8  1
1978 Lowe M, Verma AK, Boutwell RK. Ultraviolet light induces epidermal ornithine decarboxylase activity. The Journal of Investigative Dermatology. 71: 417-8. PMID 722122 DOI: 10.1111/1523-1747.Ep12558288  1
1978 Kensler TW, Verma AK, Boutwell RK, Mueller GC. Effects of retinoic acid and juvenile hormone on the induction of ornithine decarboxylase activity by 12-O-tetradecanoylphorbol-13-acetate. Cancer Research. 38: 2896-9. PMID 679197  1
1978 Verma AK, Rice HM, Shapas BG, Boutwell RK. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs (retinoids). Cancer Research. 38: 793-801. PMID 626983  1
1977 Verma AK, Boutwell RK. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Research. 37: 2196-201. PMID 861945  1
1977 Verma AK, Rice HM, Boutwell RK. Prostaglandins and skin tumor promotion: inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis. Biochemical and Biophysical Research Communications. 79: 1160-6. PMID 414746 DOI: 10.1016/0006-291X(77)91128-7  1
1977 Murray AW, Solanki V, Verma AK. Accumulation of cyclic adenosine 3',5'-monophosphate in adult and newborn mouse skin: responses to ischemia and isoproterenol. The Journal of Investigative Dermatology. 68: 125-7. PMID 190327 DOI: 10.1111/1523-1747.Ep12492238  1
1976 Verma AK, Dixon KE, Froscio M, Murray AW. Localization of adenosine o',5'-monophosphate in mouse epidermis by immunofluorescence. The Journal of Investigative Dermatology. 66: 239-41. PMID 178805 DOI: 10.1111/1523-1747.Ep12482157  1
1976 Verma AK, Froscio M, Murray AW. Croton oil- and benzo(a)pyrene-induced changes in cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities in mouse epidermis. Cancer Research. 36: 81-7. PMID 174815  1
1974 Verma AK, Murray AW. The effect of benzo(alpha)pyrene on the basal and isoproterenol-stimulated levels of cyclic adenosine 3',5'-monophosphate in mouse epidermis. Cancer Research. 34: 3408-13. PMID 4371960  1
1973 Murray AW, Verma AK. The adenyl cyclase system and carcinogenesis: decreased responsiveness of mouse epidermis to isoproterenol after 3,4-benzpyrene treatment. Biochemical and Biophysical Research Communications. 54: 69-75. PMID 4741578 DOI: 10.1016/0006-291X(73)90889-9  1
Show low-probability matches.